The removal of ubiquitin (Ub) from
a modified protein or Ub chain
is a process that occurs regularly by the ubiquitin–proteasome
system. This process is known to be mediated by various deubiquitinating
enzymes (DUBs) in order to control the protein’s half-life
and its expression levels among many other signaling processes. Since
the function of DUBs is also involved in numerous human diseases,
such as cancer, there is an obvious need for an effective diagnostic
probe that can monitor the activity of these enzymes. We have developed
the first chemiluminescence probe for detection of DUBs activity.
The probe was prepared by conjugation of the chemically synthesized
C-terminally activated Ub(1-75) with a Gly-enolether precursor. Subsequent
oxidation, under aqueous conditions, of the enolether conjuagate with
singlet-oxygen furnished the dioxetane probe
Ub-CL
. This
synthesis provides the first example of a dioxetane–luminophore
protein conjugate. The probe’s ability to detect deubiquitinating
activity was successfully validated with three different DUBs. In
order to demonstrate the advantage of our new probe, comparison measurements
for detection of DUB UCH-L3 activity were performed between the chemiluminescent
probe
Ub-CL
and the well-known
Ub-AMC
probe.
The obtained data showed significantly higher S/N, for probe
Ub-CL
(>93-fold) in comparison to that observed for
Ub-AMC
(1.5-fold). We anticipate that the successful design
and synthesis of the turn-ON protein–dioxetane conjugate probe,
demonstrated in this work, will provide the insight and motivation
for preparation of other relevant protein–dioxetane conjugates.